Boggiss Anna L, Babbott Katie, Milford Ānna, Ellett Sian, Consedine Nathan, Reid Susan, Cao Nic, Cavadino Alana, Hopkins Sarah, Jefferies Craig, de Bock Martin, Serlachius Anna
Department of Psychological Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, Aotearoa New Zealand.
Rio Tinto Children's Diabetes Centre, The Kids Research Institute Australia, Perth Children's Hospital, Perth, Western Australia, Australia.
Diabet Med. 2025 Jul 27:e70115. doi: 10.1111/dme.70115.
Although it is well established that youth with type 1 Diabetes (T1D) experience high rates of distress, current clinical care is often under-resourced and unable to provide sufficient or timely psychological support. The current study was designed to evaluate the safety, usability and feasibility of 'COMPASS,' a self-compassion chatbot intervention.
Forty adolescents (aged 12-16 years) living with T1D participated in a 12-week, single-group feasibility study using a mixed methods approach. Usability was assessed via qualitative feedback and interviews, feasibility through app analytics and recruitment data, and safety by utilisation of distress risk management protocols. Psychosocial measures (including diabetes distress, strengths and resilience, self-efficacy, self-compassion, self-care behaviours and emotional well-being) were collected at baseline, 6- and 12-week follow-ups, alongside HbA1c at baseline and 12 weeks.
Of 40 participants recruited, 32 (80%) completed the study. On average, participants completed 95% of modules started. Follow-up assessments showed promising reductions in diabetes distress, and improvements in resilience, self-efficacy, self-compassion and emotional well-being. Qualitative analysis highlighted strengths in engagement and relevance of information covered. Areas for improvement included increasing decision-making support to help alleviate the felt burden of diabetes.
The COMPASS chatbot was demonstrated to be safe, feasible and acceptable to adolescents living with T1D. Future research aims to conduct a hybrid type 1 effectiveness-implementation trial that will leverage updates in artificial intelligence to increase the flexibility and tailoring of responding.
虽然1型糖尿病(T1D)青少年的痛苦发生率很高已是公认的事实,但目前的临床护理往往资源不足,无法提供充分或及时的心理支持。本研究旨在评估自我同情聊天机器人干预措施“COMPASS”的安全性、可用性和可行性。
40名患有T1D的青少年(年龄在12 - 16岁之间)参与了一项为期12周的单组可行性研究,采用混合方法。通过定性反馈和访谈评估可用性,通过应用分析和招募数据评估可行性,通过使用痛苦风险管理协议评估安全性。在基线、6周和12周随访时收集心理社会指标(包括糖尿病痛苦、优势与复原力、自我效能感、自我同情、自我护理行为和情绪健康),同时在基线和12周时收集糖化血红蛋白(HbA1c)。
在招募的40名参与者中,32名(80%)完成了研究。参与者平均完成了所开启模块的95%。随访评估显示,糖尿病痛苦有显著降低,复原力、自我效能感、自我同情和情绪健康有所改善。定性分析突出了所涵盖信息在参与度和相关性方面的优势。有待改进的方面包括增加决策支持,以帮助减轻糖尿病带来的感知负担。
COMPASS聊天机器人被证明对患有T1D的青少年是安全、可行且可接受的。未来的研究旨在进行一项1型混合有效性 - 实施试验,该试验将利用人工智能的更新来提高响应的灵活性和针对性。